• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The outcomes of intestinal resection during debulking surgery for ovarian cancer.卵巢癌肿瘤细胞减灭术中肠切除的结果。
Turk J Surg. 2017 Jun 1;33(2):96-99. doi: 10.5152/UCD.2016.3515. eCollection 2017.
2
Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.晚期上皮性卵巢癌肿瘤减灭术中肠手术和造口形成后的临床特征和结局。
Int J Gynecol Cancer. 2019 Mar;29(3):585-592. doi: 10.1136/ijgc-2018-000154.
3
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.上皮性卵巢癌初次肿瘤细胞减灭术时的肠切除术。
J Am Coll Surg. 2001 Dec;193(6):626-32. doi: 10.1016/s1072-7515(01)01090-0.
4
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.老年共管理可确保在三级癌症中心接受治疗的晚期卵巢癌老年女性安全实施细胞减灭术。
Gynecol Oncol. 2019 Jul;154(1):77-82. doi: 10.1016/j.ygyno.2019.04.683. Epub 2019 May 8.
5
Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.直肠乙状结肠切除术和道格拉斯腹膜切除术在晚期卵巢癌手术中治疗浆膜种植的应用:生存和手术结果。
Int J Gynecol Cancer. 2018 Nov;28(9):1699-1705. doi: 10.1097/IGC.0000000000001368.
6
Bowel surgery for epithelial ovarian cancer--an early case series.上皮性卵巢癌的肠道手术——早期病例系列
Ann Acad Med Singap. 2003 Sep;32(5):661-4.
7
Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer.晚期卵巢癌患者减瘤手术中广泛肠切除的围手术期结局
J Surg Oncol. 2019 Jun;119(7):1011-1015. doi: 10.1002/jso.25403. Epub 2019 Feb 8.
8
Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer.上皮性卵巢癌初次肿瘤细胞减灭术手术并发症的相关因素。
Obstet Gynecol Sci. 2020 Jan;63(1):64-71. doi: 10.5468/ogs.2020.63.1.64. Epub 2019 Dec 31.
9
Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.医院手术量对晚期上皮性卵巢癌初次肿瘤细胞减灭术后完全大体切除(CGR)率的影响。
Gynecol Oncol. 2019 Aug;154(2):401-404. doi: 10.1016/j.ygyno.2019.05.016. Epub 2019 May 31.
10
Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.晚期恶性卵巢生殖细胞肿瘤的减瘤手术
J Gynecol Obstet Hum Reprod. 2019 Sep;48(7):461-466. doi: 10.1016/j.jogoh.2019.06.006. Epub 2019 Jun 19.

引用本文的文献

1
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis.保护性造口术在卵巢癌手术中的应用:系统评价和荟萃分析。
J Gynecol Oncol. 2022 Mar;33(2):e21. doi: 10.3802/jgo.2022.33.e21.

本文引用的文献

1
Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients.为新诊断的晚期卵巢癌患者选择最佳治疗策略。
World J Methodol. 2015 Dec 26;5(4):196-202. doi: 10.5662/wjm.v5.i4.196.
2
Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population.二次减瘤手术对亚洲人群复发性卵巢癌生存的影响
Oman Med J. 2015 Sep;30(5):344-52. doi: 10.5001/omj.2015.70.
3
Ovarian cancer.卵巢癌。
Lancet. 2014 Oct 11;384(9951):1376-88. doi: 10.1016/S0140-6736(13)62146-7. Epub 2014 Apr 21.
4
Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.手术减灭术治疗上皮性卵巢癌 30 天内住院再入院相关的患者、治疗和出院因素。
Gynecol Oncol. 2013 Sep;130(3):407-10. doi: 10.1016/j.ygyno.2013.05.034. Epub 2013 Jun 5.
5
Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?晚期卵巢癌的新辅助化疗:我们的共识与分歧是什么?
Gynecol Oncol. 2013 Jan;128(1):6-11. doi: 10.1016/j.ygyno.2012.09.013. Epub 2012 Sep 21.
6
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
7
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.2010 年妇科癌症国际协作组(GCIG)卵巢癌临床试验共识声明:第四届卵巢癌共识会议报告。
Int J Gynecol Cancer. 2011 May;21(4):750-5. doi: 10.1097/IGC.0b013e31821b2568.
8
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.评估上皮性卵巢癌手术后肿瘤细胞减灭术 30 天内再入院的风险因素。
Int J Gynecol Cancer. 2011 Jul;21(5):806-10. doi: 10.1097/IGC.0b013e3182157a19.
9
[Complications of radical surgery for advanced ovarian cancer].[晚期卵巢癌根治性手术的并发症]
Gynecol Obstet Fertil. 2011 Jan;39(1):21-7. doi: 10.1016/j.gyobfe.2010.08.017. Epub 2010 Dec 22.
10
Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.表皮生长因子受体基因突变和 Akt、ERK 异常磷酸化对卵巢癌的预后影响。
Cancer Biol Ther. 2011 Jan 1;11(1):50-7. doi: 10.4161/cbt.11.1.13877.

卵巢癌肿瘤细胞减灭术中肠切除的结果。

The outcomes of intestinal resection during debulking surgery for ovarian cancer.

作者信息

Terzioğlu Serdar Gökay, Kılıç Murat Özgür, Çetinkaya Nilüfer, Baser Eralp, Güngör Tayfun, Adıgüzel Cevdet

机构信息

Clinic of General Surgery, Numune Training and Research Hospital, Ankara, Turkey.

Clinic of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Ankara, Turkey.

出版信息

Turk J Surg. 2017 Jun 1;33(2):96-99. doi: 10.5152/UCD.2016.3515. eCollection 2017.

DOI:10.5152/UCD.2016.3515
PMID:28740958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5508250/
Abstract

OBJECTIVE

To evaluate the clinical and surgical outcomes of intestinal resection during primary debulking surgery for ovarian cancer.

MATERIAL AND METHODS

This retrospective study was conducted at Zekai Tahir Burak Women's Health Training and Research Hospital between 2009 and 2013. The patients who underwent intestinal resection during debulking surgery for stage 3 ovarian cancer were included in the analysis. Data regarding patient age, body mass index, tumor histology, disease stage, the site of intestinal resection, all postoperative complications, duration of intensive care unit admission and hospital stay were collected and analyzed.

RESULTS

A total of 22 patients with a mean age of 53.4 years were included in the study. Optimal cytoreduction was achieved in 14 (63%) patients. Transverse colectomy was the most common type of intestinal resection (63%). The most common postoperative complication was transfusion of blood products (63%). No postoperative mortality was observed.

CONCLUSION

Intestinal resection is a crucial part of debulking surgery for advanced ovarian cancer, with acceptable complication rates. Despite the limited number of patients, the results obtained from the present study are comparable with previous reports.

摘要

目的

评估卵巢癌初次肿瘤细胞减灭术中肠切除的临床及手术效果。

材料与方法

本回顾性研究于2009年至2013年在泽凯·塔希尔·布拉克妇女健康培训与研究医院开展。分析了在3期卵巢癌肿瘤细胞减灭术中接受肠切除的患者。收集并分析了患者年龄、体重指数、肿瘤组织学、疾病分期、肠切除部位、所有术后并发症、重症监护病房住院时间及住院总时长等数据。

结果

本研究共纳入22例患者,平均年龄53.4岁。14例(63%)患者实现了最佳肿瘤细胞减灭。横结肠切除术是最常见的肠切除类型(63%)。最常见的术后并发症是输注血制品(63%)。未观察到术后死亡病例。

结论

肠切除是晚期卵巢癌肿瘤细胞减灭术的关键部分,并发症发生率可接受。尽管患者数量有限,但本研究所得结果与既往报告相当。